DOI QR코드

DOI QR Code

Adjuvant Radiotherapy after Breast Conserving Treatment for Breast Cancer:A Dosimetric Comparison between Volumetric Modulated Arc Therapy and Intensity Modulated Radiotherapy

  • Liu, Zhe-Ming (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Ge, Xiao-Lin (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Chen, Jia-Yan (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Wang, Pei-Pei (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Zhang, Chi (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Yang, Xi (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Zhu, Hong-Cheng (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Liu, Jia (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Qin, Qin (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Xu, Li-Ping (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Lu, Jing (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Zhan, Liang-Liang (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University) ;
  • Cheng, Hong-Yan (Department of Synthetic Internal Medicine, The First Affiliated Hospital of Nanjing Medical University) ;
  • Sun, Xin-Chen (Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University)
  • Published : 2015.04.29

Abstract

Background: Radiotherapy is an important treatment of choice for breast cancer patients after breast-conserving surgery, and we compare the feasibility of using dual arc volumetric modulated arc therapy (VMAT2), single arc volumetric modulated arc therapy (VMAT1) and Multi-beam Intensity Modulated Radiotherapy (M-IMRT) on patients after breast-conserving surgery. Materials and Methods: Thirty patients with breast cancer (half right-sided and half left-sided) treated by conservative lumpectomy and requiring whole breast radiotherapy with tumor bed boost were planned with three different radiotherapy techniques: 1) VMAT1; 2) VMAT2; 3) M-IMRT. The distributions for the planning target volume (PTV) and organs at risk (OARs) were compared. Dosimetries for all the techniques were compared. Results: All three techniques satisfied the dose constraint well. VMAT2 showed no obvious difference in the homogeneity index (HI) and conformity index (CI) of the PTV with respect to M-IMRT and VMAT1. VMAT2 clearly improved the treatment efficiency and can also decrease the mean dose and V5Gy of the contralateral lung. The mean dose and maximum dose of the spinal cord and contralateral breast were lower for VMAT2 than the other two techniques. The very low dose distribution (V1Gy) of the contralateral breast also showed great reduction in VMAT2 compared with the other two techniques. For the ipsilateral lung of right-sided breast cancer, the mean dose was decreased significantly in VMAT2 compared with VMAT1 and M-IMRT. The V20Gy and V30Gy of the ipsilateral lung of the left-sided breast cancer for VMAT2 showed obvious reduction compared with the other two techniques. The heart statistics of VMAT2 also decreased considerably compared to VMAT1 and M-IMRT. Conclusions: Compared to the other two techniques, the dual arc volumetric modulated arc therapy technique reduced radiation dose exposure to the organs at risk and maintained a reasonable target dose distribution.

Keywords

Breast cancer;VMAT;IMRT;dosimetry;DVH

References

  1. Askoxylakis V, Jensen AD, Hafner MF, et al (2011). Simultaneous integrated boost for adjuvanttreatment of breast cancer--intensity modulated vs. conventional radiotherapy: the IMRT-MC2 trial. BMC Cancer, 11, 249. https://doi.org/10.1186/1471-2407-11-249
  2. Badakhshi H, Kaul D, Nadobny J, et al (2013). Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy. Br J Radiol, 86, 20130515. https://doi.org/10.1259/bjr.20130515
  3. Bartelink H, Horiot JC, Poortmans PM, et al (2007). Impact of a higher radiation dose on local control and survival in breastconserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol, 25, 3259-65. https://doi.org/10.1200/JCO.2007.11.4991
  4. Bartelink H, Maingon P, Poortmans P, et al (2015). Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial. Lancet Oncol, 16, 47-56. https://doi.org/10.1016/S1470-2045(14)71156-8
  5. Beckham WA, Popescu CC, Patenaude VV, Wai ES, Olivotto IA (2007). Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer? Int J Radiat Oncol Biol Phys, 69, 918-24. https://doi.org/10.1016/j.ijrobp.2007.06.060
  6. Brooks JD, Boice JJ, Stovall M, et al (2012). Reproductive status at first diagnosis influences risk of radiation-induced second primary contralateral breast cancer in the WECARE study. Int J Radiat Oncol Biol Phys, 84, 917-24. https://doi.org/10.1016/j.ijrobp.2012.01.047
  7. Cao JQ, Olson RA, Tyldesley SK (2013). Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer. Curr Oncol, 20, 593-601. https://doi.org/10.3747/co.20.1543
  8. Collette S, Collette L, Budiharto T, et al (2008). Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'. Eur J Cancer, 44, 2587-99. https://doi.org/10.1016/j.ejca.2008.07.032
  9. Eccles SA, Aboagye EO, Ali S, et al (2013). Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res, 15, 92. https://doi.org/10.1186/bcr3493
  10. Feuvret L, Noel G, Mazeron JJ, Bey P (2006). Conformity index:a review. Int J Radiat Oncol Biol Phys, 64, 333-42. https://doi.org/10.1016/j.ijrobp.2005.09.028
  11. Hijal T, Fournier-Bidoz N, Castro-Pena P, et al (2010). Simultaneous integrated boost in breast conserving treatment of breast cancer: a dosimetric comparison of helical tomotherapy and three-dimensional conformal radiotherapy. Radiother Oncol, 94, 300-6. https://doi.org/10.1016/j.radonc.2009.12.043
  12. Huang XB, Jiang GL, Chen JY, et al (2008). Dosimetrical optimization study of intensity modulated radiotherapy for intact breast. China Oncol, 18, 832-7.
  13. Hurkmans CW, Meijer GJ, van Vliet-Vroegindeweij C, et al (2006). High-dose simultaneously integrated breast boost using intensity-modulated radiotherapy and inverse optimization. Int J Radiat Oncol Biol Phys, 66, 923-30. https://doi.org/10.1016/j.ijrobp.2006.05.041
  14. Jabbari K (2011). Review of fast monte carlo codes for dose calculation in radiation therapy treatment planning. J Med Signals Sens, 1, 73-86.
  15. Jin GH, Chen LX, Deng XW, et al (2013). A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques:conventional tangential field, filed-in-filed, tangential-IMRT, multi-beam IMRT and VMAT. Radiat Oncol, 8, 89. https://doi.org/10.1186/1748-717X-8-89
  16. Johansen S, Cozzi L, Olsen DR (2009). A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques. Acta Oncol, 48, 495-503. https://doi.org/10.1080/02841860802657227
  17. Kaviani A, Sodagari N, Sheikhbahaei S, et al (2013). From radical mastectomy to breast-conserving therapy and oncoplastic breast surgery: a narrative review comparing oncological result, cosmetic outcome, quality of life, and health economy. ISRN Oncol, 2013, 742462.
  18. Kim MJ, Park SH, Son SH, et al (2013). Comparison study of the partial-breast irradiation techniques: dosimetric analysis of three-dimensional conformal radiation therapy, electron beam therapy, and helical tomotherapy depending on various tumor locations. Med Dosim, 38, 327-31. https://doi.org/10.1016/j.meddos.2013.03.004
  19. Kirova YM, Vilcoq JR, Asselain B, Sastre-Garau X, Fourquet A (2005). Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer, 104, 856-63. https://doi.org/10.1002/cncr.21223
  20. Kirova YM, Gambotti L, De Rycke Y, et al (2007). Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. Int J Radiat Oncol Biol Phys, 68, 359-63. https://doi.org/10.1016/j.ijrobp.2006.12.011
  21. Kirova YM, De Rycke Y, Gambotti L, et al (2008). Second malignancies after breast cancer: the impact of different treatment modalities. Br J Cancer, 98, 870-4. https://doi.org/10.1038/sj.bjc.6604241
  22. Kraus-Tiefenbacher U, Sfintizky A, Welzel G, et al (2012). Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiat Oncol, 7, 217. https://doi.org/10.1186/1748-717X-7-217
  23. Liljegren A, Unukovych D, Gagliardi G, et al (2014). No difference in dose distribution in organs at risk in postmastectomy radiotherapy with or without breast implant reconstruction. Radiat Oncol, 9, 14. https://doi.org/10.1186/1748-717X-9-14
  24. Lohr F, Heggemann F, Papavassiliu T, et al (2009). Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT? Strahlenther Onkol, 185, 222-30. https://doi.org/10.1007/s00066-009-1892-0
  25. McCormack VA, Boffetta P (2011). Today's lifestyles, tomorrow's cancers: trends in lifestyle risk factors for cancer in low- and middle-income countries. Ann Oncol, 22, 2349-57. https://doi.org/10.1093/annonc/mdq763
  26. Michalski A, Atyeo J, Cox J, et al (2014). A dosimetric comparison of 3D-CRT, IMRT, and static tomotherapy with an SIB for large and small breast volumes. Med Dosim, 39, 163-8. https://doi.org/10.1016/j.meddos.2013.12.003
  27. Ning ZH, Mu JM, Jin JX, et al (2013). Single arc volumetricmodulated arc therapy is sufficient for nasopharyngeal carcinoma: a dosimetric comparison with dual arc VMAT and dynamic MLC and step-and-shoot intensity-modulated radiotherapy. Radiat Oncol, 8, 237. https://doi.org/10.1186/1748-717X-8-237
  28. Onal C, Sonmez S, Erbay G, Guler OC, Arslan G (2014). Simultaneous integrated boost to intraprostatic lesions using different energy levels of intensity-modulated radiotherapy and volumetric-arc therapy. Br J Radiol, 87, 20130617. https://doi.org/10.1259/bjr.20130617
  29. Pignol JP, Olivotto I, Rakovitch E, et al (2008). A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol, 26, 2085-92. https://doi.org/10.1200/JCO.2007.15.2488
  30. Popescu CC, Olivotto IA, Beckham WA, et al (2010). Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensitymodulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys, 76, 287-95. https://doi.org/10.1016/j.ijrobp.2009.05.038
  31. Rudat V, Alaradi AA, Mohamed A, Ai-Yahya K, Altuwaijri S (2011). Tangential beam IMRT versus tangential beam 3D-CRT of the chest wall in postmastectomy breast cancer patients: a dosimetric comparison. Radiat Oncol, 6, 26. https://doi.org/10.1186/1748-717X-6-26
  32. Saibishkumar EP, MacKenzie MA, Severin D, et al (2008). Skinsparing radiation using intensity-modulated radiotherapy after conservative surgery in early-stage breast cancer: a planning study. Int J Radiat Oncol Biol Phys, 70, 485-91. https://doi.org/10.1016/j.ijrobp.2007.06.049
  33. Singla R, King S, Albuquerque K, Creech S, Dogan N (2006). Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma. Med Dosim, 31, 190-6. https://doi.org/10.1016/j.meddos.2005.11.001
  34. Taylor CW, Bronnum D, Darby SC, et al (2011). Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001. Radiother Oncol, 100, 176-83. https://doi.org/10.1016/j.radonc.2011.01.020
  35. Thilmann C, Zabel A, Milker-Zabel S, et al (2003). Number and orientation of beams in inversely planned intensitymodulated radiotherapy of the female breast and the parasternal lymph nodes. Am J Clin Oncol, 26, 136-43. https://doi.org/10.1097/01.coc.0000091354.75297.42
  36. van der Laan HP, Dolsma WV, Maduro JH, et al (2007). Threedimensional conformal simultaneously integrated boost technique for breast-conserving radiotherapy. Int J Radiat Oncol Biol Phys, 68, 1018-23. https://doi.org/10.1016/j.ijrobp.2007.01.037
  37. Xu X-l, Wu H, Han S-k, et al (2006). Dosimetry study of intensity modulated radiation therapy for left side breast cancer. Chinese J Radiat Oncol, 15, 192-5.